Ankylose This! Living with Ankylosing Spondylitis

Friday, April 28, 2006

Humira recommended for AS in Europe

The Associated Press reports that the anti-TNF drug Humira (adalimumab) has been recommended for approval in Europe for the treatment of severe and active ankylosing spondylitis by the scientific committee of the European Medicines Agency. A decision on approval is expected within 60 days.

See previous entries: Adalimumab (Humira) and ankylosing spondylitis; More about adalimumab.

Update, 4/29: AFX News in Forbes.

Comments on this post

  • My Rheumy just mentioned this medication to me as a potential option for my AS, although it's not approved here yet, as I just lost my access to Enbrel. :( Does anyone know what the status of FDA approval is of Humira for AS in the states?

    Posted by Anonymous Boulder Chick (5/10/2006 9:34 PM)  

Post a Comment

Links to this post

Create a Link